13117-01-6

Usage

Uses

Used in Pharmaceutical Research and Development:
ZM-241385 is utilized as a research tool and potential therapeutic agent for targeting the adenosine A2A receptor. Its selectivity and potency in antagonizing this receptor make it valuable for investigating the receptor's role in various diseases and for developing new treatments.
Used in Neurodegenerative Disease Treatment:
In the field of neurodegenerative diseases, ZM-241385 is used as a potential therapeutic agent for conditions like Parkinson's disease. Its action on the adenosine A2A receptor is believed to modulate neuronal activity and potentially slow disease progression.
Used in Inflammation Management:
ZM-241385 is also considered for use in managing inflammation due to the adenosine A2A receptor's involvement in inflammatory processes. By antagonizing this receptor, ZM-241385 may help in reducing inflammation and associated symptoms.
Used in Cancer Therapy:
In oncology, ZM-241385 has been studied for its potential applications in cancer treatment. The adenosine A2A receptor's role in tumor growth and progression makes ZM-241385 a candidate for investigating its effects on cancer cells and possibly enhancing the efficacy of existing cancer therapies.
Used in Drug Development:
As a compound with a clear target and established pharmacological properties, ZM-241385 is used in the development of new drugs that aim to treat a variety of conditions by modulating the adenosine A2A receptor. This includes the design and synthesis of novel compounds that may have improved efficacy, selectivity, or reduced side effects compared to existing treatments.